Jazz Pharmaceuticals plc Comprehensive Income
Jazz Pharmaceuticals plc (JAZZ) reported Comprehensive Income of $181.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-03
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $181.30M.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $210.70M, a 203.17% increase year-over-year.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $204.75M.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $167.28M, a 66.54% decline year-over-year.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $22.92M, a 94.96% decline from fiscal 2024.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $454.60M, a 34.89% decline from fiscal 2023.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $698.19M.
- Jazz Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$949.21M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $181.30M 10-Q · filed 2026-08-03 | $392.00M 10-Q · filed 2026-08-03 | $596.75M derived: sum of 3 quarters · filed 2026-08-03 | $764.03M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | $210.70M 10-Q · filed 2026-05-05 | $415.45M derived: sum of 2 quarters · filed 2026-05-05 | $582.73M derived: sum of 3 quarters · filed 2026-05-05 | $164.13M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | $204.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $372.03M derived: sum of 2 quarters · filed 2026-02-24 | -$46.57M derived: sum of 3 quarters · filed 2026-08-03 | $22.92M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $167.28M 10-Q · filed 2025-11-05 | -$251.32M derived: sum of 2 quarters · filed 2026-08-03 | -$181.83M 10-Q · filed 2025-11-05 | -$334.97M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | -$418.60M 10-Q · filed 2026-08-03 | -$418.63M 10-Q · filed 2025-08-06 | -$349.10M 10-Q · filed 2026-08-03 | -$349.11M 10-Q · filed 2025-08-06 | -$502.25M derived: sum of 3 quarters · filed 2026-08-03 | -$2.37M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $69.50M 10-Q · filed 2026-05-05 | $69.52M 10-Q · filed 2025-05-07 | -$83.66M derived: sum of 2 quarters · filed 2026-05-05 | $416.23M derived: sum of 3 quarters · filed 2026-05-05 | $578.97M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$153.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $346.73M derived: sum of 2 quarters · filed 2026-02-24 | $509.46M derived: sum of 3 quarters · filed 2026-02-24 | $454.60M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $499.88M 10-Q · filed 2025-11-05 | $662.62M derived: sum of 2 quarters · filed 2025-11-05 | $607.75M 10-Q · filed 2025-11-05 | $895.16M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $162.74M 10-Q · filed 2025-08-06 | $107.87M 10-Q · filed 2025-08-06 | $395.28M derived: sum of 3 quarters · filed 2026-02-24 | $373.52M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | -$54.87M 10-Q · filed 2025-05-07 | $232.54M derived: sum of 2 quarters · filed 2026-02-24 | $210.78M derived: sum of 3 quarters · filed 2026-02-24 | $428.63M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $287.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $265.65M derived: sum of 2 quarters · filed 2026-02-24 | $483.50M derived: sum of 3 quarters · filed 2026-02-24 | $698.19M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | -$21.76M 10-Q · filed 2024-11-07 | $196.09M derived: sum of 2 quarters · filed 2024-11-07 | $410.79M 10-Q · filed 2024-11-07 | $662.20M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $217.84M 10-Q · filed 2024-08-01 | $432.54M 10-Q · filed 2024-08-01 | $683.96M derived: sum of 3 quarters · filed 2025-02-26 | $152.69M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $214.70M 10-Q · filed 2024-05-02 | $466.11M derived: sum of 2 quarters · filed 2025-02-26 | -$65.15M derived: sum of 3 quarters · filed 2025-02-26 | -$545.80M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $251.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$279.85M derived: sum of 2 quarters · filed 2025-02-26 | -$760.50M derived: sum of 3 quarters · filed 2025-02-26 | -$949.21M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$531.26M 10-Q · filed 2023-11-08 | -$1.01B derived: sum of 2 quarters · filed 2023-11-08 | -$1.20B 10-Q · filed 2023-11-08 | -$1.24B derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | -$480.64M 10-Q · filed 2023-08-09 | -$669.36M 10-Q · filed 2023-08-09 | -$707.55M derived: sum of 3 quarters · filed 2024-02-28 | -$966.97M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$188.71M 10-Q · filed 2023-05-10 | -$226.91M derived: sum of 2 quarters · filed 2024-02-28 | -$486.32M derived: sum of 3 quarters · filed 2024-02-28 | -$861.14M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | -$38.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$297.61M derived: sum of 2 quarters · filed 2024-02-28 | -$672.43M derived: sum of 3 quarters · filed 2024-02-28 | -$595.68M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$259.42M 10-Q · filed 2022-11-09 | -$634.24M derived: sum of 2 quarters · filed 2022-11-09 | -$557.48M 10-Q · filed 2022-11-09 | -$370.62M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | -$374.82M 10-Q · filed 2022-08-03 | -$298.07M 10-Q · filed 2022-08-03 | -$111.20M derived: sum of 3 quarters · filed 2023-03-01 | $85.34M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $76.76M 10-Q · filed 2022-05-04 | $263.62M derived: sum of 2 quarters · filed 2023-03-01 | $460.16M derived: sum of 3 quarters · filed 2023-03-01 | $596.29M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $186.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $383.40M derived: sum of 2 quarters · filed 2023-03-01 | $519.53M derived: sum of 3 quarters · filed 2023-03-01 | $327.66M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $196.54M 10-Q · filed 2021-11-09 | $332.67M derived: sum of 2 quarters · filed 2021-11-09 | $140.79M 10-Q · filed 2021-11-09 | $250.84M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $136.13M 10-Q · filed 2021-08-03 | -$55.75M 10-Q · filed 2021-08-03 | $54.29M derived: sum of 3 quarters · filed 2022-03-01 | $107.56M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$191.88M 10-Q · filed 2021-05-04 | -$81.83M derived: sum of 2 quarters · filed 2022-03-01 | -$28.57M derived: sum of 3 quarters · filed 2022-03-01 | $243.57M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $110.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $163.31M derived: sum of 2 quarters · filed 2022-03-01 | $435.45M derived: sum of 3 quarters · filed 2022-03-01 | $497.76M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $53.27M 10-Q · filed 2020-11-02 | $325.41M derived: sum of 2 quarters · filed 2020-11-02 | $387.72M 10-Q · filed 2020-11-02 | $528.87M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-06-30 | $272.14M 10-Q · filed 2020-08-04 | $334.45M 10-Q · filed 2020-08-04 | $475.60M derived: sum of 3 quarters · filed 2021-02-23 | $613.68M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-03-31 | $62.32M 10-Q · filed 2020-05-05 | $203.46M derived: sum of 2 quarters · filed 2021-02-23 | $341.54M derived: sum of 3 quarters · filed 2021-02-23 | $364.40M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | $141.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $279.22M derived: sum of 2 quarters · filed 2021-02-23 | $302.08M derived: sum of 3 quarters · filed 2021-02-23 | $390.13M 10-K · filed 2021-02-23 | |||
| 2018-09-30 | $138.08M 10-Q · filed 2019-11-05 | $160.94M derived: sum of 2 quarters · filed 2019-11-05 | $248.99M 10-Q · filed 2019-11-05 | $499.30M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $22.86M 10-Q · filed 2019-08-06 | $110.91M 10-Q · filed 2019-08-06 | $361.23M derived: sum of 3 quarters · filed 2020-02-25 | $476.01M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $88.05M 10-Q · filed 2019-05-07 | $338.36M derived: sum of 2 quarters · filed 2020-02-25 | $453.15M derived: sum of 3 quarters · filed 2020-02-25 | $648.35M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $250.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $365.10M derived: sum of 2 quarters · filed 2020-02-25 | $560.30M derived: sum of 3 quarters · filed 2020-02-25 | $664.30M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $114.79M 10-Q · filed 2018-11-06 | $309.99M derived: sum of 2 quarters · filed 2018-11-06 | $413.99M 10-Q · filed 2018-11-06 | $448.72M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $195.20M 10-Q · filed 2018-08-07 | $299.20M 10-Q · filed 2018-08-07 | $333.93M derived: sum of 3 quarters · filed 2019-02-26 | $438.37M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $104.00M 10-Q · filed 2018-05-08 | $138.73M derived: sum of 2 quarters · filed 2019-02-26 | $243.17M derived: sum of 3 quarters · filed 2019-02-26 | $329.97M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $34.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $139.17M derived: sum of 2 quarters · filed 2019-02-26 | $225.97M derived: sum of 3 quarters · filed 2019-02-26 | $346.97M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $104.44M 10-Q · filed 2017-11-07 | $101.76M 10-Q · filed 2016-11-08 | $191.24M derived: sum of 2 quarters · filed 2017-11-07 | $312.24M 10-Q · filed 2017-11-07 | $304.64M 10-Q · filed 2016-11-08 | $358.80M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | $86.80M 10-Q · filed 2017-08-08 | $83.58M 10-Q · filed 2016-08-09 | $207.80M 10-Q · filed 2017-08-08 | $202.89M 10-Q · filed 2016-08-09 | $254.36M derived: sum of 3 quarters · filed 2018-02-27 | $359.09M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $121.00M 10-Q · filed 2017-05-09 | $119.31M 10-Q · filed 2016-05-10 | $167.57M derived: sum of 2 quarters · filed 2018-02-27 | $272.29M derived: sum of 3 quarters · filed 2018-02-27 | $390.95M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $46.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $151.29M derived: sum of 2 quarters · filed 2018-02-27 | $269.95M derived: sum of 3 quarters · filed 2018-02-27 | $184.16M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $104.72M 10-Q · filed 2016-11-08 | $223.38M derived: sum of 2 quarters · filed 2016-11-08 | $137.59M 10-Q · filed 2016-11-08 | $154.24M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $118.66M 10-Q · filed 2016-08-09 | $32.87M 10-Q · filed 2016-08-09 | $49.52M derived: sum of 3 quarters · filed 2017-02-28 | -$41.80M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | -$85.79M 10-Q · filed 2016-05-10 | -$69.14M derived: sum of 2 quarters · filed 2017-02-28 | -$160.45M derived: sum of 3 quarters · filed 2017-02-28 | -$127.74M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $16.65M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$74.67M derived: sum of 2 quarters · filed 2017-02-28 | -$41.95M derived: sum of 3 quarters · filed 2017-02-28 | -$119.86M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$91.31M 10-Q · filed 2015-11-09 | -$58.60M derived: sum of 2 quarters · filed 2015-11-09 | -$136.51M 10-Q · filed 2015-11-09 | -$69.69M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | $32.71M 10-Q · filed 2015-08-05 | -$45.20M 10-Q · filed 2015-08-05 | $21.63M derived: sum of 3 quarters · filed 2016-02-23 | $122.44M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | -$77.91M 10-Q · filed 2015-05-07 | -$11.09M derived: sum of 2 quarters · filed 2016-02-23 | $89.72M derived: sum of 3 quarters · filed 2016-02-23 | $140.52M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $66.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $167.63M derived: sum of 2 quarters · filed 2016-02-23 | $218.43M derived: sum of 3 quarters · filed 2016-02-23 | $241.42M 10-K · filed 2016-02-23 | |||
| 2013-09-30 | $100.81M 10-Q · filed 2014-11-04 | $151.61M derived: sum of 2 quarters · filed 2014-11-04 | $174.59M 10-Q · filed 2014-11-04 | $392.33M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $50.80M 10-Q · filed 2014-08-05 | $73.78M 10-Q · filed 2014-08-05 | $291.52M derived: sum of 3 quarters · filed 2015-02-24 | $338.98M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $22.98M 10-Q · filed 2014-05-08 | $240.72M derived: sum of 2 quarters · filed 2015-02-24 | $288.18M derived: sum of 3 quarters · filed 2015-02-24 | $314.93M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $217.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $265.19M derived: sum of 2 quarters · filed 2015-02-24 | $291.95M derived: sum of 3 quarters · filed 2015-02-24 | $319.66M 10-K · filed 2015-02-24 | |||
| 2012-09-30 | $47.46M 10-Q · filed 2013-11-05 | $74.21M derived: sum of 2 quarters · filed 2013-11-05 | $101.93M 10-Q · filed 2013-11-05 | $139.37M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $26.75M 10-Q · filed 2013-08-06 | $54.47M 10-Q · filed 2013-08-06 | $91.91M derived: sum of 3 quarters · filed 2014-02-25 | $124.39M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $27.71M 10-Q · filed 2013-05-07 | $65.16M derived: sum of 2 quarters · filed 2014-02-25 | $97.64M derived: sum of 3 quarters · filed 2014-02-25 | $130.84M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $37.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $69.92M derived: sum of 2 quarters · filed 2014-02-25 | $103.13M derived: sum of 3 quarters · filed 2014-02-25 | $124.95M 10-K · filed 2014-02-25 | |||
| 2011-09-30 | $32.48M 10-Q · filed 2012-11-09 | $65.68M derived: sum of 2 quarters · filed 2012-11-09 | $87.51M 10-Q · filed 2012-11-09 | ||||
| 2011-06-30 | $33.20M 10-Q · filed 2012-08-07 | $55.03M 10-Q · filed 2012-08-07 | |||||
| 2011-03-31 | $21.83M 10-Q · filed 2012-05-08 | ||||||
| 2010-12-31 | $32.78M 10-K · filed 2013-02-26 | ||||||
| 2009-12-31 | -$6.84M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |